Redox regulation of Brn-2/N-Oct-3 POU domain DNA binding activity and proteolytic formation of N-Oct-5 during melanoma cell nuclear extraction

Melanoma Research

Volumn 8, Issue 1, 1998, Pages 2-10

  Smith, A G ^a   Brightwell, G ^a   Smit, S E ^a   Parsons, P G ^b   Sturm, R A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Apoptosis; Diamide; Oxidation; POU domain; Proteolysis; Transcription factor

Indexed keywords

CYSTEINE; DIAMIDE; DISULFIDE; DNA; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN BRN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; DISULFIDE BOND; MELANOMA CELL; MOLECULAR RECOGNITION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN DOMAIN;

ANIMALS; BLOTTING, WESTERN; CELL NUCLEUS; COS CELLS; DIAMIDE; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HOMEODOMAIN PROTEINS; HUMANS; HYDROGEN PEROXIDE; MELANOMA; MELANOMA, EXPERIMENTAL; METALS; MICE; OXIDATION-REDUCTION; POU DOMAIN FACTORS; RABBITS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0031940655     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199802000-00002     Document Type: Article

References (33)

1. Eisen T. The control of gene expression in melanocytes and melanomas. Melanoma Res 1996; 6: 277-284.
2. Scholer HR, Hatzopoulos AK, Balling R, Suzuki N, Gruss P. A family of octamer specific proteins present during mouse embryogenesis: evidence for germline specific expression of an Oct factor. EMBO J 1989; 8: 2543-2550.
3. Schreiber E, Harshman K, Kemler I, Malipiero U, Schaffner W, Fontana A. Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B-cell Oct-2 proteins. Nucleic Acids Res 1990; 18: 5495-5503.
4. Schreiber E, Himmelmann A, Malipiero U, Tobler A, Stahel R, Fontana A. Human small cell lung cancer expresses the octamer DNA-binding and nervous system specific transcription factor N-Oct-3 (Brain-2). Cancer Res 1992; 52: 6121-6124.
5. Schreiber E, Tobler A, Malipiero U, Schaffner W, Fontana A. cDNA cloning of human N-Oct-3, a nervous system specific POU domain transcription factor binding to the octamer DNA motif. Nucleic Acids Res 1993; 21: 253-258.
6. Sturm RA, O'Sullivan BJ, Thomson JAF, Jamshidi N, Pedley J, Parsons PG. Expression studies of pigmentation and POU domain genes in human melanoma cells. Pigment Cell Res 1994; 7: 235-240.
7. Sturm RA, Bishop F, Takahashi H, Parsons PG. A melanoma octamer binding protein is responsive to differentiating agents. Cell Growth Diff 1991; 2: 519-524.
8. Thomson JAF, Parsons PG, Sturm RA. In vivo and in vitro expression of octamer binding proteins in human melanoma metastases, brain tissue and fibroblasts. Pigment Cell Res 1993; 6: 13-22.
9. Eisen T, Easty DJ, Bennett DC, Coding CR. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte specific gene expression. Oncogene 1995; 11: 2157 2164.
10. Thomson JAF, Murphy K, Baker E, Sutherland GR, Parsons PG, Sturm RA. The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells. Oncogene 1995; 11: 691-700.
11. Ammendola R, Mesuraca M, Russo T, Cimino F. The DNA binding efficiency of Sp1 is affected by redox changes. Eur J Biochem 1994; 225: 482-489.
12. Yao KS, Xanthoudakis S, Curran T, Odwyer PJ. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol Cell Biol 1994; 14: 5997-6003.
13. Tong L, Perez-Polo JR. Transcription factor DNA binding activity in PC12 cells undergoing apoptosis after glucose deprivation. Neurosci Lett 1995; 191: 137 140.
14. Devary Y, Gottlieb RA, Smeal T, Karin M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 1992; 71: 1081-1091.
15. Rigoni P, Xu L, Harshman K, Schaffner W, Arnosti DN. Conserved cysteine residues of Oct-2 POU domain confer sensitivity to oxidation but are dispensible for sequence specific DNA binding. Biochim Biophys Acta 1993; 1173: 141-146.
16. Lickteig K, Lamb K, Brigman K, Rizzino A. Effects of oxidation and reduction on the binding of transcription factors to the cis-regulatory elements located in the FGF-4 gene. Mol Reprod Dev 1996; 44: 146-152.
17. Ron D, Dressler H. pGSTag - a versatile bacterial expression plasmid for enzymatic labelling of recombinant proteins. Biotechniques 1992; 13: 866-869.
18. Smith DB, Johnson KS. Single step purification of polypeptides expressed in E. coli as fusions with glutathione S-transferase. Gene 1988; 67: 31-40.
19. Harlow E, Lane D. Antibodies: A Laboratory Manual. New York, Cold Spring Harbor, 1988.
20. O'Halloran TV. Transition metals in control of gene expression. Science 1993; 261: 715-725.
21. Stadtman ER, Oliver CN. Metal-catalyzed oxidation of proteins. J Biol Chem 1991; 266: 2005-2008.
22. Kosower NS, Kosower EM. Diamide: an oxidant probe for thiols. Methods Enzymol 1995; 251: 123-133.
23. Mather EL. DNA-binding factors of B lymphoid cells are susceptible to limited proteolytic cleavage during nuclear extract preparation. Mol Cell Biol 1988; 8: 1812-1815.
24. Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with 'miniextracts' prepared from a small number of cells. Nucleic Acids Res 1989; 17: 6419.
25. Wang S, Pittman RN. Altered protein binding to the octamer motif appears to be an early event in programmed neuronal cell death. Proc Natl Acad Sci USA 1993; 90: 10385 10389.
26. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an anti-oxidant pathway to prevent apoptosis. Cell 1993; 75: 241-251.
27. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE. Bcl-2 inhibition of neural death - decreased generation of reactive oxygen species. Science 1993; 262: 1274-1277.
28. White E. Life, death and the pursuit of apoptosis. Genes Dev 1996; 10: 1-15.
29. Bolognia JL, Sodi SA, Osber MP, Pawelek JM. Enhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoximine. Br J Dermatol 1995; 133: 349-357.
30. Busciglio J, Yanker BA. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 1995; 378: 776-779.
31. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. Beta-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 1996; 380: 168-171.
32. Stadtman ER. Protein oxidation and aging. Science 1992; 257: 1220-1224.
33. Scholtz B, Lamb K, Rosfjord E, Kingsley M, Rizzino A. Appearance of nuclear protease activity after embryonal carcinoma cells undergo differentiation. Dev Biol 1996; 173: 420-427.